These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33196524)

  • 1. Development of a New Chelation Model: Bioassay Data Interpretation and Dose Assessment after Plutonium Intake via Wound and Treatment with DTPA.
    Dumit S; Miller G; Klumpp JA; Poudel D; Bertelli L; Waters TL
    Health Phys; 2020 Dec; 119(6):715-732. PubMed ID: 33196524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating Plutonium Intake and Radiation Dose Following Extensive Chelation Treatment.
    Dumit S; Avtandilashvili M; Tolmachev SY
    Health Phys; 2019 Aug; 117(2):156-167. PubMed ID: 29750674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose Assessment Following a 238Pu-contaminated Wound Case with Chelation and Excision.
    Poudel D; Klumpp JA; Bertelli L; Dumit S; Waters TL
    Health Phys; 2020 Dec; 119(6):690-703. PubMed ID: 33196522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chelation Modeling: The Use of Ad Hoc Models and Approaches to Overcome a Dose Assessment Challenge.
    Dumit S; Bertelli L; Klumpp JA; Poudel D; Waters TL
    Health Phys; 2020 Feb; 118(2):193-205. PubMed ID: 31833972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a system of models for plutonium decorporation therapy.
    Dumit S; Avtandilashvili M; McComish SL; Strom DJ; Tabatadze G; Tolmachev SY
    Radiat Environ Biophys; 2019 May; 58(2):227-235. PubMed ID: 30627772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Modeling of Plutonium-DTPA Decorporation.
    Dumit S; Avtandilashvili M; Strom DJ; McComish SL; Tabatadze G; Tolmachev SY
    Radiat Res; 2019 Feb; 191(2):201-210. PubMed ID: 30566387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of a puncture wound case with medical intervention.
    Bailey BR; Eckerman KF; Townsend LW
    Radiat Prot Dosimetry; 2003; 105(1-4):509-12. PubMed ID: 14527019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Response, Dose Assessment, and Clinical Management of a Plutonium-contaminated Puncture Wound.
    Sugarman SL; Findley WM; Toohey RE; Dainiak N
    Health Phys; 2018 Jul; 115(1):57-64. PubMed ID: 29787431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USTUR WHOLE-BODY CASE 0212: 17-YEAR FOLLOW-UP OF PLUTONIUM CONTAMINATED WOUND.
    Avtandilashvili M; Dumit S; Tolmachev SY
    Radiat Prot Dosimetry; 2018 Jan; 178(2):160-169. PubMed ID: 28985407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches.
    Fritsch P; Grappin L; Guillermin AM; Fottorino R; Ruffin M; Mièle A
    Radiat Prot Dosimetry; 2007; 127(1-4):120-4. PubMed ID: 17562647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpretation of Urinary Excretion Data From Plutonium Wound Cases Treated With DTPA: Application of Different Models and Approaches.
    Poudel D; Bertelli L; Klumpp JA; Waters TL
    Health Phys; 2017 Jul; 113(1):30-40. PubMed ID: 28542009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plutonium-DTPA Model Application with USTUR Case 0269.
    Konzen K; Brey R; Miller S
    Health Phys; 2016 Jan; 110(1):59-65. PubMed ID: 26606066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
    Breustedt B; Blanchardon E; Berard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-four years of follow-up for a Hanford plutonium wound case.
    Carbaugh EH; Lynch TP; Antonio CL; Medina-Del Valle F
    Health Phys; 2010 Oct; 99(4):483-94. PubMed ID: 20838089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CONRAD approach to biokinetic modeling of DTPA decorporation therapy.
    Breustedt B; Blanchardon E; Bérard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Health Phys; 2010 Oct; 99(4):547-52. PubMed ID: 20838097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ustur whole body case 0269: demonstrating effectiveness of i.v. CA-DTPA for Pu.
    James AC; Sasser LB; Stuit DB; Glover SE; Carbaugh EH
    Radiat Prot Dosimetry; 2007; 127(1-4):449-55. PubMed ID: 18227077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chelation Model Validation: Modeling of a Plutonium-238 Inhalation Incident Treated with DTPA at Los Alamos National Laboratory.
    Dumit S; Miller G; Poudel D; Bertelli L; Klumpp J
    Health Phys; 2023 Feb; 124(2):113-124. PubMed ID: 36625835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-decade follow-up of a plutonium-contaminated puncture wound treated with Ca-DTPA.
    Avtandilashvili M; Tolmachev SY
    J Radiol Prot; 2021 Nov; 41(4):. PubMed ID: 34034246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of Pu-238 during Long-term Chelation Therapy by Repeated DTPA Inhalation.
    Grémy O; Blanchin N; Miccoli L
    Health Phys; 2022 Sep; 123(3):197-207. PubMed ID: 35613373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.